Valuation Vivos Therapeutics, Inc.
Stocks
VVOS
US92859E2072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
16:00:00 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 0.1611 USD | -1.53% |
|
-5.35% | -92.06% |
Company Valuation: Vivos Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 51.78 | 9.251 | 14.89 | 25.27 | 18.25 | 3.241 | - |
| Change | - | -82.13% | 61% | 69.64% | -27.79% | -82.24% | - |
| Enterprise Value (EV) | 51.78 | 9.251 | 14.89 | 25.27 | 18.25 | 3.241 | 3.241 |
| Change | - | -82.13% | 61% | 69.64% | -27.79% | -82.24% | 0% |
| P/E | -2.34x | -0.39x | -1.12x | -1.93x | -0.98x | -0.12x | -0.2x |
| PBR | - | - | 36.9x | 3.18x | -12.7x | - | - |
| PEG | - | -0.05x | 0x | 0x | 0.15x | 0x | 0x |
| Capitalization / Revenue | 3.07x | 0.58x | 1.08x | 1.68x | 1.05x | 0.15x | 0.1x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.15x | 0.1x |
| EV / EBITDA | - | -0x | - | - | -0x | -0.17x | -5.85x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.16x | -0.26x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -24 | -26 | -11.14 | -2.22 | -2.07 | -1.342 | -0.8233 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 16.88 | 16.02 | 13.8 | 15.03 | 17.44 | 21.79 | 34.09 |
| EBITDA 1 | - | -24.36 | - | - | -18.58 | -18.72 | -0.554 |
| EBIT 1 | -20.38 | -25.03 | -17.3 | -11.17 | -19.89 | -20.41 | -12.34 |
| Net income 1 | -20.29 | -23.84 | -13.58 | -11.14 | -21.17 | -23.53 | -14.7 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 56.2500 | 10.0500 | 12.4400 | 4.2900 | 2.0300 | 0.1611 | 0.1611 |
| Nbr of stocks (in thousands) | 920 | 920 | 1,197 | 5,890 | 8,988 | 20,118 | - |
| Announcement Date | 3/31/22 | 3/30/23 | 3/28/24 | 3/31/25 | 4/15/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.12x | - | - | - | 3.24M | ||
| 72.2x | 7.59x | 44.28x | -.--% | 12.54B | ||
| 20.66x | 2.09x | 10.27x | 2.15% | 6.69B | ||
| 37.23x | 1.75x | 10.92x | -.--% | 6.3B | ||
| 27.58x | 5.69x | 15.39x | 1.38% | 5.6B | ||
| 33.47x | 9.9x | 25.01x | 0.6% | 5.04B | ||
| 17.64x | 2.94x | 15.3x | 3.53% | 3.85B | ||
| -12.97x | 2.46x | -22.37x | - | 1.89B | ||
| -17.96x | 434.33x | -77.29x | -.--% | 1.75B | ||
| 18.82x | 2.31x | 9.07x | 2.02% | 1.61B | ||
| Average | 19.66x | 52.12x | 3.40x | 1.21% | 4.53B | |
| Weighted average by Cap. | 36.30x | 21.71x | 17.69x | 0.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VVOS Stock
- Valuation Vivos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















